Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projects/586-combination-of-ibrutinib-and-bortezomib-followed-by-ibrutinib-maintenance-to-treat-patients-with-relapsed-and-refractory-mantle-cell-lymphoma-a-multicenter-phase-iii-trial